4.21
Foghorn Therapeutics Inc Aktie (FHTX) Neueste Nachrichten
Identifying reversal signals in Foghorn Therapeutics Inc.2025 Market Overview & Fast Moving Stock Watchlists - newser.com
Is Foghorn Therapeutics Inc. stock safe for conservative investorsBull Run & Free Weekly Watchlist of Top Performers - newser.com
How Foghorn Therapeutics Inc. stock valuations compare to rivalsPrice Action & AI Driven Stock Movement Reports - newser.com
Foghorn Therapeutics to engage investors at oncology conferences - Traders Union
Foghorn Therapeutics Inc. to Participate in Major Healthcare Conferences in November 2025 - Quiver Quantitative
Foghorn Therapeutics (NASDAQ: FHTX) plans three investor events; webcasts for 90 days - Stock Titan
Is Foghorn Therapeutics Inc. stock bottoming outAnalyst Upgrade & Accurate Intraday Trade Tips - newser.com
Applying big data sentiment scoring on Foghorn Therapeutics Inc.Short Setup & Real-Time Market Trend Scan - newser.com
Published on: 2025-11-03 02:03:18 - newser.com
Why Foghorn Therapeutics Inc. stock could outperform in 2025Market Growth Report & Low Volatility Stock Recommendations - newser.com
Will Foghorn Therapeutics Inc. continue its uptrendWeekly Market Outlook & High Accuracy Buy Signal Tips - newser.com
How moving averages guide Foghorn Therapeutics Inc. tradingMarket Growth Report & Weekly Top Gainers Trade List - newser.com
Can swing trading help recover from Foghorn Therapeutics Inc. lossesJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Published on: 2025-11-02 02:35:38 - newser.com
Can trapped investors hope for a rebound in Foghorn Therapeutics Inc.Market Performance Report & Verified Stock Trade Ideas - newser.com
Why Foghorn Therapeutics Inc. is moving todayPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Published on: 2025-11-01 05:22:36 - newser.com
What does recent volatility data suggest for Foghorn Therapeutics Inc.Watch List & Free Verified High Yield Trade Plans - newser.com
Foghorn Therapeutics shares progress on three protein degrader programs - BioWorld MedTech
Has Foghorn Therapeutics Inc. formed a bullish divergencePortfolio Performance Report & Long-Term Growth Portfolio Plans - newser.com
Foghorn Therapeutics advances ARID1B, CBP, EP300 development - Traders Union
Foghorn Therapeutics Announces Key Pipeline Updates - TipRanks
Foghorn Therapeutics Announces Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs - The Manila Times
Foghorn Therapeutics Updates on Selective Degrader Programs and Virtual Investor Event Announcement - Quiver Quantitative
Foghorn Therapeutics Inc Announces Pipeline Updates for Degrader Programs - TradingView
Foghorn Therapeutics Announces Updates for Selective - GlobeNewswire
Momentum divergence signals in Foghorn Therapeutics Inc. chartQuarterly Portfolio Report & AI Forecast for Swing Trade Picks - newser.com
How risky is Foghorn Therapeutics Inc. stock nowEarnings Growth Report & Consistent Profit Trading Strategies - newser.com
Volatility clustering patterns for Foghorn Therapeutics Inc.Quarterly Market Review & Long Hold Capital Preservation Plans - newser.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):